Authors:
BURRELL LM
PHILLIPS PA
RISVANIS J
CHAN RK
ALDRED KL
JOHNSTON CI
Citation: Lm. Burrell et al., LONG-TERM EFFECTS OF NONPEPTIDE VASOPRESSIN V-2 ANTAGONIST OPC-31260 IN HEART-FAILURE IN THE RAT, American journal of physiology. Heart and circulatory physiology, 44(1), 1998, pp. 176-182
Citation: K. Yoshida et al., HYPOTENSIVE EFFECT OF ZD7155, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, PARALLELS RECEPTOR OCCUPANCY IN 2-KIDNEY, ONE-CLIP GOLDBLATT HYPERTENSIVE RATS, Journal of hypertension, 16(5), 1998, pp. 645-655
Citation: I. Koukoulas et al., CHARACTERIZATION OF THE SHEEP VASOPRESSIN V1A RECEPTOR GENE PROMOTER REGION, Journal of hypertension, 16, 1998, pp. 130-130
Citation: Nk. Farina et al., NEUTRAL ENDOPEPTIDASE ANGIOTENSIN CONVERTING-ENZYME INHIBITION ATTENUATES REMODELING IN HEART-FAILURE/, Journal of hypertension, 16, 1998, pp. 146-146
Authors:
TIKKANEN T
TIKKANEN I
ROCKELL M
JOHNSTON CI
COOPER ME
BURRELL LM
Citation: T. Tikkanen et al., DUAL NEUTRAL ENDOPEPTIDASE ANGIOTENSIN CONVERTING-ENZYME INHIBITION IN RATS WITH HYPERTENSION AND DIABETES-MELLITUS/, Journal of hypertension, 16, 1998, pp. 1707-1707
Authors:
TIKKANEN T
TIKKANEN I
ROCKELL MD
ALLEN TJ
JOHNSTON CI
COOPER ME
BURRELL LM
Citation: T. Tikkanen et al., DUAL INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME IN RATS WITH HYPERTENSION AND DIABETES-MELLITUS, Hypertension, 32(4), 1998, pp. 778-785
Authors:
YOSHIDA K
KANAZAWA M
CASLEY DJ
KATOPOTHIS A
JOHNSTON CI
Citation: K. Yoshida et al., INHIBITION OF KIDNEY NEUTRAL ENDOPEPTIDASE AFTER ADMINISTRATION OF THE NEUTRAL ENDOPEPTIDASE INHIBITOR CANDOXATRIL - QUANTITATION BY AUTORADIOGRAPHY, Journal of cardiovascular pharmacology, 32(5), 1998, pp. 702-708
Authors:
YOSHIDA K
KOHZUKI M
CASLEY DJ
JOHNSTON CI
Citation: K. Yoshida et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND SALT IN EXPERIMENTAL MYOCARDIAL-INFARCTION, Journal of cardiovascular pharmacology, 32(3), 1998, pp. 357-365
Authors:
RISVANIS J
JOHNSTON CI
PHILLIPS PA
BURRELL LM
Citation: J. Risvanis et al., VASOPRESSIN V1A AND V2 RECEPTOR MESSENGER-RNA IN DEOXYCORTICOSTERONE ACETATE SALT HYPERTENSION IN THE RAT, Clinical science, 94(5), 1998, pp. 517-523
Authors:
YOSHIDA K
YASUJIMA M
CASLEY DJ
JOHNSTON CI
Citation: K. Yoshida et al., EFFECT OF CHRONIC NEUTRAL ENDOPEPTIDASE INHIBITION ON CARDIAC-HYPERTROPHY AFTER EXPERIMENTAL MYOCARDIAL-INFARCTION, Japanese Circulation Journal, 62(9), 1998, pp. 680-686
Authors:
WING LMH
REID CM
RYAN P
BEILIN LJ
BROWN MA
JENNINGS GLR
JOHNSTON CI
MCNEIL JJ
MARLEY JE
MORGAN TO
SHAW J
STEVEN ID
WEST MJ
Citation: Lmh. Wing et al., 2ND AUSTRALIAN NATIONAL BLOOD-PRESSURE STUDY (ANBP2) - AUSTRALIAN COMPARATIVE OUTCOME TRIAL OF ACE INHIBITOR-BASED AND DIURETIC-BASED TREATMENT OF HYPERTENSION IN THE ELDERLY, Clinical and experimental hypertension, 19(5-6), 1997, pp. 779-791
Citation: Ci. Johnston, NEW PHARMACOLOGICAL APPROACHES TO THE MANAGEMENT OF HYPERTENSION - INTRODUCTION, American journal of hypertension, 10(12), 1997, pp. 299-299
Citation: Ci. Johnston et J. Risvanis, PRECLINICAL PHARMACOLOGY OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS - UPDATE AND OUTSTANDING ISSUES, American journal of hypertension, 10(12), 1997, pp. 306-310
Authors:
NAITOH M
BURRELL LM
RISVANIS J
ALDRED KL
ROCKELL MD
JOHNSTON CI
PHILLIPS PA
Citation: M. Naitoh et al., MODULATION OF GENETIC-HYPERTENSION BY SHORT-TERM AVP V-1A OR V-2 RECEPTOR ANTAGONISM IN YOUNG SHR, American journal of physiology. Renal, fluid and electrolyte physiology, 41(2), 1997, pp. 229-234
Authors:
BLACK MJ
BRISCOE T
BERTRAM JF
JACKSON B
JOHNSTON CI
Citation: Mj. Black et al., CARDIAC-HYPERTROPHY IN DIABETIC SPONTANEOUSLY HYPERTENSIVE RATS - ROLE OF ANGIOTENSIN-II, Clinical and experimental pharmacology and physiology, 24(6), 1997, pp. 445-448
Authors:
REID CM
NELSON M
BECKINSALE P
RYAN P
WING LMH
BEILIN LJ
BROWN MA
JENNINGS GLR
JOHNSTON CI
MARLEY J
MCNEIL JJ
MORGAN TO
SHAW J
STEVEN ID
WEST MJ
Citation: Cm. Reid et al., FEASIBILITY OF CONDUCTING CARDIOVASCULAR OUTCOME RESEARCH IN AUSTRALIAN GENERAL-PRACTICE - RESULTS FROM THE ANBP2 PILOT-STUDY, Clinical and experimental pharmacology and physiology, 24(5), 1997, pp. 370-373
Authors:
WING LMH
REID CM
BEILIN LJ
BROWN MA
JENNINGS GLR
JOHNSTON CI
MCNEIL JJ
MARLEY JE
MORGON TO
RYAN P
SHAW J
STEVEN ID
WEST MJ
Citation: Lmh. Wing et al., AUSTRALIAN COMPARATIVE OUTCOME TRIAL OF ANGIOTENSIN-CONVERTING ENZYMEINHIBITOR-BASED AND DIURETIC-BASED TREATMENT OF HYPERTENSION IN THE ELDERLY (ANBP2) - OBJECTIVES AND PROTOCOL, Clinical and experimental pharmacology and physiology, 24(2), 1997, pp. 188-192
Citation: Ci. Johnston et al., RATIONALE AND PHARMACOLOGY OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CURRENT STATUS AND FUTURE-ISSUES, Journal of hypertension, 15, 1997, pp. 3-6
Authors:
JANDELEITDAHM K
BURRELL LM
JOHNSTON CI
KOCH KM
Citation: K. Jandeleitdahm et al., ELEVATED VASCULAR ANGIOTENSIN-CONVERTING ENZYME MEDIATES INCREASED NEOINTIMA FORMATION AFTER BALLOON INJURY IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of hypertension, 15(6), 1997, pp. 643-650
Authors:
BURRELL LM
FARINA N
RISVANIS J
WOOLLARD D
CASELY D
JOHNSTON CI
Citation: Lm. Burrell et al., INHIBITION OF NEUTRAL ENDOPEPTIDASE, THE DEGRADATIVE ENZYME FOR NATRIURETIC PEPTIDES, IN RAT-KIDNEY AFTER ORAL SCH-42495, Clinical science, 93(1), 1997, pp. 43-50
Citation: I. Tikkanen et Ci. Johnston, COMPARISON OF RENIN-ANGIOTENSIN TO CALCIUM-CHANNEL BLOCKADE IN RENAL-DISEASE, Kidney international, 1997, pp. 19-22